These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30262728)

  • 1. Histone Deacetylases Enhance Ca
    Matsui M; Terasawa K; Kajikuri J; Kito H; Endo K; Jaikhan P; Suzuki T; Ohya S
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of KCa3.1 K(+) channel in mesenteric lymph node CD4(+) T lymphocytes from a mouse model of dextran sodium sulfate-induced inflammatory bowel disease.
    Ohya S; Fukuyo Y; Kito H; Shibaoka R; Matsui M; Niguma H; Maeda Y; Yamamura H; Fujii M; Kimura K; Imaizumi Y
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(10):G873-85. PubMed ID: 24674776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Interleukin-10 Expression by the Inhibition of Ca
    Ohya S; Matsui M; Kajikuri J; Endo K; Kito H
    J Pharmacol Exp Ther; 2021 Apr; 377(1):75-85. PubMed ID: 33504590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of candesartan on KCa3.1 potassium channel expression and cell culture and proliferation in peripheral blood CD4
    Li H; Zhao JL; Zhang YM; Han SX
    Clin Exp Hypertens; 2018; 40(4):303-311. PubMed ID: 29388859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+ -activated K+ channel-3.1 blocker TRAM-34 alleviates murine allergic rhinitis.
    Lin H; Zheng C; Li J; Yang C; Hu L
    Int Immunopharmacol; 2014 Dec; 23(2):642-8. PubMed ID: 25466273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the intermediate-conductance Ca(2+)-activated K+ channel inhibits the angiogenesis induced by epidermal growth factor in the treatment of corneal alkali burn.
    Yang H; Li X; Ma J; Lv X; Zhao S; Lang W; Zhang Y
    Exp Eye Res; 2013 May; 110():76-87. PubMed ID: 23482085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.
    Zhang Y; Feng Y; Chen L; Zhu J
    Cell Biochem Biophys; 2015 Jun; 72(2):515-25. PubMed ID: 25608633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
    Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
    Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.
    Yu ZH; Xu JR; Wang YX; Xu GN; Xu ZP; Yang K; Wu DZ; Cui YY; Chen HZ
    Am J Respir Cell Mol Biol; 2013 Jun; 48(6):685-93. PubMed ID: 23492185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis.
    Koch Hansen L; Sevelsted-Møller L; Rabjerg M; Larsen D; Hansen TP; Klinge L; Wulff H; Knudsen T; Kjeldsen J; Köhler R
    J Crohns Colitis; 2014 Nov; 8(11):1378-91. PubMed ID: 24793818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.
    Hua X; Deuse T; Chen YJ; Wulff H; Stubbendorff M; Köhler R; Miura H; Länger F; Reichenspurner H; Robbins RC; Schrepfer S
    Transplantation; 2013 Jan; 95(2):285-92. PubMed ID: 23325003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voltage dependence of the Ca(2+)-activated K(+) channel K(Ca)3.1 in human erythroleukemia cells.
    Stoneking CJ; Shivakumar O; Thomas DN; Colledge WH; Mason MJ
    Am J Physiol Cell Physiol; 2013 May; 304(9):C858-72. PubMed ID: 23407879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role and mechanism of K
    Ma XZ; Pang ZD; Wang JH; Song Z; Zhao LM; Du XJ; Deng XL
    Exp Cell Res; 2018 Aug; 369(2):208-217. PubMed ID: 29792849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K
    Bonito B; Sauter DR; Schwab A; Djamgoz MB; Novak I
    Pflugers Arch; 2016 Nov; 468(11-12):1865-1875. PubMed ID: 27752766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis.
    Di L; Srivastava S; Zhdanova O; Ding Y; Li Z; Wulff H; Lafaille M; Skolnik EY
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1541-6. PubMed ID: 20080610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury.
    Chen CL; Liao JW; Hu OY; Pao LH
    Arch Toxicol; 2016 Sep; 90(9):2249-2260. PubMed ID: 26438401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of vascular calcification by block of intermediate conductance calcium-activated potassium channels with TRAM-34.
    Freise C; Querfeld U
    Pharmacol Res; 2014 Jul; 85():6-14. PubMed ID: 24813858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K
    Lu R; Flauaus C; Kennel L; Petersen J; Drees O; Kallenborn-Gerhardt W; Ruth P; Lukowski R; Schmidtko A
    Neuropharmacology; 2017 Oct; 125():386-395. PubMed ID: 28823609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
    Xie H; Lu J; Zhu Y; Meng X; Wang R
    Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiological Role of K(+) Channels in the Regulation of T Cell Function].
    Ohya S
    Yakugaku Zasshi; 2016; 136(3):479-83. PubMed ID: 26935090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.